These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 29251996)

  • 1. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists.
    Lewis JS; Beadle B; Bishop JA; Chernock RD; Colasacco C; Lacchetti C; Moncur JT; Rocco JW; Schwartz MR; Seethala RR; Thomas NE; Westra WH; Faquin WC
    Arch Pathol Lab Med; 2018 May; 142(5):559-597. PubMed ID: 29251996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.
    Fakhry C; Lacchetti C; Rooper LM; Jordan RC; Rischin D; Sturgis EM; Bell D; Lingen MW; Harichand-Herdt S; Thibo J; Zevallos J; Perez-Ordonez B
    J Clin Oncol; 2018 Nov; 36(31):3152-3161. PubMed ID: 30188786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma: Impact of the 2018 College of American Pathologists Guideline Among Referral Cases at a Large Academic Institution.
    Ferguson DC; Mehrad M; Ely KA; Shinn JR; Lewis JS
    Arch Pathol Lab Med; 2021 Sep; 145(9):1123-1131. PubMed ID: 33373453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of high-risk human papillomavirus mRNA in situ hybridisation in squamous cell carcinoma of unknown primary in the head and neck and implementing American Society of Clinical Oncology guideline recommendations.
    Daneshpajouhnejad P; Miller JA; Maleki Z
    Cytopathology; 2020 Nov; 31(6):547-554. PubMed ID: 32735747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk human papillomavirus testing in cytology aspiration samples from the head and neck part 1: a review of the literature on available testing options.
    Manucha V; Adeniran AJ; Asiry S; Hoda RS; Johnson DN; van Zante A; VandenBussche CJ; Griffith CC;
    J Am Soc Cytopathol; 2022; 11(5):295-305. PubMed ID: 35810109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Perspective on HPV-Associated Oropharyngeal Carcinomas and the Role of p16 as a Surrogate Marker of High-Risk HPV.
    Gurín D; Slávik M; Shatokhina T; Kazda T; Šána J; Slabý O; Hermanová M
    Klin Onkol; 2019; 32(4):252-260. PubMed ID: 31426640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma at One of the Largest Tertiary Care Centers in Sub-Saharan Africa.
    Dapaah G; Hille J; Faquin WC; Whittaker J; Dittrich CM; Ebrahim AK; Schneider JW; van Wyk AC; Opperman J; Merven M; Naidoo K; Loock JW; Afrogheh AH
    Arch Pathol Lab Med; 2022 Aug; 146(8):1018-1023. PubMed ID: 34871360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
    Song SJ; Jalaly JB
    Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
    Ribeiro EA; Maleki Z
    J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oropharyngeal Squamous Cell Carcinoma With Discordant p16 and HPV mRNA Results: Incidence and Characterization in a Large, Contemporary United States Cohort.
    Shinn JR; Davis SJ; Lang-Kuhs KA; Rohde S; Wang X; Liu P; Dupont WD; Plummer D; Thorstad WL; Chernock RD; Mehrad M; Lewis JS
    Am J Surg Pathol; 2021 Jul; 45(7):951-961. PubMed ID: 33739785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
    Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
    Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus Testing in Head and Neck Squamous Cell Carcinoma in 2020: Where Are We Now and Where Are We Going?
    Lewis JS
    Head Neck Pathol; 2020 Jun; 14(2):321-329. PubMed ID: 32124415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
    Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
    Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
    Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
    Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.